Anti-MRSA β-lactams in development, with a focus on ceftobiprole: the first anti-MRSA β-lactam to demonstrate clinical efficacy

Karen Bush, Markus Heep, Mark J Macielag, Gary J Noel
  • Expert Opinion on Investigational Drugs, March 2007, Informa Healthcare
  • DOI: 10.1517/13543784.16.4.419

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1517/13543784.16.4.419

The following have contributed to this page: Dr. Karen Bush